The effects of Rimexolone 1% in postoperative inflammation after cataract extraction. A double-masked placebo-controlled study. [electronic resource]
Producer: 19980706Description: 16-21 p. digitalISSN:- 1120-6721
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents -- administration & dosage
- Anti-Inflammatory Agents -- administration & dosage
- Cataract Extraction -- adverse effects
- Double-Blind Method
- Drug Therapy, Combination
- Endophthalmitis -- drug therapy
- Female
- Follow-Up Studies
- Humans
- Lens Implantation, Intraocular -- adverse effects
- Male
- Middle Aged
- Ophthalmic Solutions
- Postoperative Complications -- drug therapy
- Pregnadienes -- administration & dosage
- Safety
- Tobramycin -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.